Oestradiol and insulin-like growth factor-1 reduce cell loss after global ischaemia in middle-aged female rats

M. L. Traub, M. De Butte-Smith, R. Suzanne Zukin, A. M. Etgen

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Whereas the ability of oestradiol and insulin-like growth factor (IGF)-1 to afford neuroprotection against ischaemia-induced neuronal death in young female and male rodents is well established, the impact of IGF-1 in middle-aged animals is largely unknown. The present study assessed the efficacy of oestradiol and IGF-1 with respect to reducing neuronal death after transient global ischaemia in middle-aged female rats after 8 weeks of hormone withdrawal. Rats were ovariohysterectomised and implanted 8 weeks later with an osmotic mini-pump delivering IGF-1 or saline into the lateral ventricle. Some rats also received physiological levels of oestradiol by subcutaneous pellet. Two weeks later, rats were subjected to global ischaemia or sham operation. Surviving hippocampal CA1 neurones were quantified. Ischaemia produced massive CA1 cell death compared to sham-operated animals, which was evident at 14 days. Significantly more neurones survived in animals treated with either oestradiol or IGF-1, but simultaneous treatment produced no additive effect. IGF-1, an endogenous growth factor, may be a clinically useful therapy in preventing human brain injury, with neuroprotective equivalence to oestradiol but without the harmful side-effects.

Original languageEnglish (US)
Pages (from-to)1038-1044
Number of pages7
JournalJournal of Neuroendocrinology
Volume21
Issue number12
DOIs
StatePublished - Dec 2009

Fingerprint

Somatomedins
Estradiol
Ischemia
Neurons
Lateral Ventricles
Brain Injuries
Rodentia
Intercellular Signaling Peptides and Proteins
Cell Death
Hormones

Keywords

  • Global ischaemia
  • IGF-1
  • Neuroprotection
  • Oestrogens

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Endocrine and Autonomic Systems
  • Cellular and Molecular Neuroscience

Cite this

Oestradiol and insulin-like growth factor-1 reduce cell loss after global ischaemia in middle-aged female rats. / Traub, M. L.; De Butte-Smith, M.; Zukin, R. Suzanne; Etgen, A. M.

In: Journal of Neuroendocrinology, Vol. 21, No. 12, 12.2009, p. 1038-1044.

Research output: Contribution to journalArticle

@article{87ceeb874c0d48e681b789dac4582b84,
title = "Oestradiol and insulin-like growth factor-1 reduce cell loss after global ischaemia in middle-aged female rats",
abstract = "Whereas the ability of oestradiol and insulin-like growth factor (IGF)-1 to afford neuroprotection against ischaemia-induced neuronal death in young female and male rodents is well established, the impact of IGF-1 in middle-aged animals is largely unknown. The present study assessed the efficacy of oestradiol and IGF-1 with respect to reducing neuronal death after transient global ischaemia in middle-aged female rats after 8 weeks of hormone withdrawal. Rats were ovariohysterectomised and implanted 8 weeks later with an osmotic mini-pump delivering IGF-1 or saline into the lateral ventricle. Some rats also received physiological levels of oestradiol by subcutaneous pellet. Two weeks later, rats were subjected to global ischaemia or sham operation. Surviving hippocampal CA1 neurones were quantified. Ischaemia produced massive CA1 cell death compared to sham-operated animals, which was evident at 14 days. Significantly more neurones survived in animals treated with either oestradiol or IGF-1, but simultaneous treatment produced no additive effect. IGF-1, an endogenous growth factor, may be a clinically useful therapy in preventing human brain injury, with neuroprotective equivalence to oestradiol but without the harmful side-effects.",
keywords = "Global ischaemia, IGF-1, Neuroprotection, Oestrogens",
author = "Traub, {M. L.} and {De Butte-Smith}, M. and Zukin, {R. Suzanne} and Etgen, {A. M.}",
year = "2009",
month = "12",
doi = "10.1111/j.1365-2826.2009.01927.x",
language = "English (US)",
volume = "21",
pages = "1038--1044",
journal = "Journal of Neuroendocrinology",
issn = "0953-8194",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Oestradiol and insulin-like growth factor-1 reduce cell loss after global ischaemia in middle-aged female rats

AU - Traub, M. L.

AU - De Butte-Smith, M.

AU - Zukin, R. Suzanne

AU - Etgen, A. M.

PY - 2009/12

Y1 - 2009/12

N2 - Whereas the ability of oestradiol and insulin-like growth factor (IGF)-1 to afford neuroprotection against ischaemia-induced neuronal death in young female and male rodents is well established, the impact of IGF-1 in middle-aged animals is largely unknown. The present study assessed the efficacy of oestradiol and IGF-1 with respect to reducing neuronal death after transient global ischaemia in middle-aged female rats after 8 weeks of hormone withdrawal. Rats were ovariohysterectomised and implanted 8 weeks later with an osmotic mini-pump delivering IGF-1 or saline into the lateral ventricle. Some rats also received physiological levels of oestradiol by subcutaneous pellet. Two weeks later, rats were subjected to global ischaemia or sham operation. Surviving hippocampal CA1 neurones were quantified. Ischaemia produced massive CA1 cell death compared to sham-operated animals, which was evident at 14 days. Significantly more neurones survived in animals treated with either oestradiol or IGF-1, but simultaneous treatment produced no additive effect. IGF-1, an endogenous growth factor, may be a clinically useful therapy in preventing human brain injury, with neuroprotective equivalence to oestradiol but without the harmful side-effects.

AB - Whereas the ability of oestradiol and insulin-like growth factor (IGF)-1 to afford neuroprotection against ischaemia-induced neuronal death in young female and male rodents is well established, the impact of IGF-1 in middle-aged animals is largely unknown. The present study assessed the efficacy of oestradiol and IGF-1 with respect to reducing neuronal death after transient global ischaemia in middle-aged female rats after 8 weeks of hormone withdrawal. Rats were ovariohysterectomised and implanted 8 weeks later with an osmotic mini-pump delivering IGF-1 or saline into the lateral ventricle. Some rats also received physiological levels of oestradiol by subcutaneous pellet. Two weeks later, rats were subjected to global ischaemia or sham operation. Surviving hippocampal CA1 neurones were quantified. Ischaemia produced massive CA1 cell death compared to sham-operated animals, which was evident at 14 days. Significantly more neurones survived in animals treated with either oestradiol or IGF-1, but simultaneous treatment produced no additive effect. IGF-1, an endogenous growth factor, may be a clinically useful therapy in preventing human brain injury, with neuroprotective equivalence to oestradiol but without the harmful side-effects.

KW - Global ischaemia

KW - IGF-1

KW - Neuroprotection

KW - Oestrogens

UR - http://www.scopus.com/inward/record.url?scp=70949097002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70949097002&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2826.2009.01927.x

DO - 10.1111/j.1365-2826.2009.01927.x

M3 - Article

C2 - 19840235

AN - SCOPUS:70949097002

VL - 21

SP - 1038

EP - 1044

JO - Journal of Neuroendocrinology

JF - Journal of Neuroendocrinology

SN - 0953-8194

IS - 12

ER -